Wechselwirkungen · Celsentri
CELSENTRI 150 mg film-coated tablets CELSENTRI 300 mg film-coated tablets · Abschnitt 4.5 · PDF-Seite 13
HOS-118472 · Präparat HOS-094825
The effect of maraviroc on digoxin at the dose of 600 mg BID has not been studied. ORAL CONTRACEPTIVES Ethinylestradiol 30 mcg QD Ethinylestradiol. AUCt: ↔ 1.00 CELSENTRI 300 mg (maraviroc 100 mg BID) Ethinylestradiol. Cmax: ↔ 0.99 twice daily. and Maraviroc concentrations not ethinylestradiol can be measured, no interaction expected. co-administered without dose adjustment. Levonorgestrel 150 mcg Levonorgestrel. AUC12: ↔ 0.98 CELSENTRI 300 mg QD Levonorgestrel. Cmax: ↔ 1.01 twice daily and (maraviroc 100 mg BID) Maraviroc concentrations not levonorgestrel can be measured, no interaction expected. co-administered without dose adjustment. SEDATIVES Benzodiazepines Midazolam 7.5 mg Single Midazolam. AUC: ↔ 1.18 CELSENTRI 300 mg Dose Midazolam. Cmax: ↔ 1.21 twice daily and (maraviroc 300 mg BID) Maraviroc concentrations not midazolam can be measured, no interaction expected. co-administered without dose adjustment. HERBAL PRODUCTS
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
RxNorm-Namen im Text (wörtliche Treffer, Rolle nicht bewertet): levonorgestrel (HOS-089677) digoxin (HOS-086172) midazolam (HOS-086167)
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-01-12T15:51:00Z · SHA-256 af7f0c7bbfd6e612d5a885c59ba9795f11ee85b00c3e0504de2a206af5fbec72 · Passage 40d216cfb6e333fdc70d362757ff433faf429c59eb7b1536b3293f426e4db8ec · Zeichen 22673–24345 im Abschnitt